Catalyst Wire Dossier Catalyst Wire Dossier

Basaglar

insulin glargine · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Basaglar, covering 2017-03-21 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan [Phase 4]

See pricing